SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-19-003376
Filing Date
2019-03-14
Accepted
2019-03-14 17:51:55
Documents
1
Period of Report
2018-12-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 3047
  Complete submission text file 0001493152-19-003376.txt   4765
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Issuer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 230 N SPRINGER LOS ALTOS CA 94024
Business Address
Barnett Brian Gill (Reporting) CIK: 0001763358 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-52218 | Film No.: 19682188